[caption id="attachment_11501" align="alignright" width="200"]
Scott Palmer, MD, MHS[/caption]
Mary Klotman, MD, chair of the Department of Medicine, shared the following message today with faculty, fellows, residents and staff.
I’m pleased to share the news that Scott Palmer, MD, MHS, associate professor of medicine with tenure in the Division of Pulmonary, Allergy and Critical Care Medicine, has agreed to serve as Vice Chair for Research for the Department.
Scott replaces Monica Kraft, MD, who stepped down earlier this year to become chief of the Division of Pulmonary, Allergy and Critical Care Medicine.
I look forward to Scott’s leadership and oversight of our research activities. The Department’s research portfolio is large and critically important to the institution. Indeed, among clinical departments in the School of Medicine, the Department of Medicine accounts for a majority of research funding. There are 292 Medicine faculty with some research funding – more than $174 million in federal expenditures (direct and indirect) and $140 million in non-federal expenditures (direct and indirect) in fiscal year 2012. And each year, you co-author more than 1,200 peer-reviewed research articles.
Scott brings much experience and perspective to his new role. He is a graduate of Oberlin College. He earned his M.D. and M.H.S. at Duke, and completed his residency and fellowship training in pulmonary, allergy and critical care medicine here. A member of the faculty since 1999, he currently serves as Duke’s Scientific Director for Transplant, Director of Pulmonary Research at the Duke Clinical Research Institute, and Associate Director of the Clinical Research Training Program in the School of Medicine.
Scott’s own research interests include laboratory and clinical research in transplantation, including immune and genetic mechanisms of obliterative bronchiolitis (the subject of his recent grand rounds presentation). His work has received continuous support through NIH and industry grants, his publications span the Annals of Internal Medicine to the Journal of Immunology, and his research accomplishments were recognized last year with election to the American Society for Clinical Investigation. His broad clinical, translational and basic research interests will support the growth and development of our research mission.
Scott joins the Department’s research leadership team that includes Ken Lyles, MD, director of the Medicine Clinical Research Unit, Tom Ortel, MD, PhD, director of lab-based research, Dee Gunn, MD, coordinator of the Medicine Research Development Council, and Laurianne Torres, director of research administration.
Please join me in welcoming Scott to his new role.
Scott Palmer, MD, MHS[/caption]
Mary Klotman, MD, chair of the Department of Medicine, shared the following message today with faculty, fellows, residents and staff.
I’m pleased to share the news that Scott Palmer, MD, MHS, associate professor of medicine with tenure in the Division of Pulmonary, Allergy and Critical Care Medicine, has agreed to serve as Vice Chair for Research for the Department.
Scott replaces Monica Kraft, MD, who stepped down earlier this year to become chief of the Division of Pulmonary, Allergy and Critical Care Medicine.
I look forward to Scott’s leadership and oversight of our research activities. The Department’s research portfolio is large and critically important to the institution. Indeed, among clinical departments in the School of Medicine, the Department of Medicine accounts for a majority of research funding. There are 292 Medicine faculty with some research funding – more than $174 million in federal expenditures (direct and indirect) and $140 million in non-federal expenditures (direct and indirect) in fiscal year 2012. And each year, you co-author more than 1,200 peer-reviewed research articles.
Scott brings much experience and perspective to his new role. He is a graduate of Oberlin College. He earned his M.D. and M.H.S. at Duke, and completed his residency and fellowship training in pulmonary, allergy and critical care medicine here. A member of the faculty since 1999, he currently serves as Duke’s Scientific Director for Transplant, Director of Pulmonary Research at the Duke Clinical Research Institute, and Associate Director of the Clinical Research Training Program in the School of Medicine.
Scott’s own research interests include laboratory and clinical research in transplantation, including immune and genetic mechanisms of obliterative bronchiolitis (the subject of his recent grand rounds presentation). His work has received continuous support through NIH and industry grants, his publications span the Annals of Internal Medicine to the Journal of Immunology, and his research accomplishments were recognized last year with election to the American Society for Clinical Investigation. His broad clinical, translational and basic research interests will support the growth and development of our research mission.
Scott joins the Department’s research leadership team that includes Ken Lyles, MD, director of the Medicine Clinical Research Unit, Tom Ortel, MD, PhD, director of lab-based research, Dee Gunn, MD, coordinator of the Medicine Research Development Council, and Laurianne Torres, director of research administration.
Please join me in welcoming Scott to his new role.